in normal men , the administration of somatostatin almost completely abolished the glucose stimulated insulin-release seen during control studies ( without somatostatin ) , and caused a further reduction in glucagon secretion beyond that induced by hyperglycemia .
C0021641
insulin
C0020456
hyperglycemia